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Background/aim: This study aimed to assess the validity and reliability of the Turkish version of the DSM-5 Generalized Anxiety
Disorder Severity Scale - Child Form.
Materials and methods: The study sample consisted of 32 patients treated in a child psychiatry unit and diagnosed with generalized
anxiety disorder and 98 healthy volunteers who were attending middle or high school during the study period. For the assessment,
the Screen for Child Anxiety and Related Emotional Disorders (SCARED) was also used along with the DSM-5 Generalized Anxiety
Disorder Severity Scale - Child Form.
Results: Regarding reliability analyses, the Cronbach alpha internal consistency coefficient was calculated as 0.932. The test–retest
correlation coefficient was calculated as r = 0.707. As for construct validity, one factor that could explain 62.6% of the variance was
obtained and this was consistent with the original construct of the scale. As for concurrent validity, the scale showed a high correlation
with SCARED.
Conclusion: It was concluded that Turkish version of the DSM-5 Generalized Anxiety Disorder Severity Scale - Child Form could be
utilized as a valid and reliable tool both in clinical practice and for research purposes.
Key words: DSM-5, Generalized Anxiety Disorder Severity Scale - Child Form, reliability, validity

1. Introduction
Anxiety disorders are among the most common
psychiatric disorders seen in childhood. Reported rates
vary from 8.3% to 27% related to a joint evaluation of
lifetime prevalence with impairments in functioning. The
second most commonly encountered anxiety disorder
is generalized anxiety disorder (GAD), and its reported
prevalence is 15% (1).
GAD is a condition where an individual has extreme
anxiety and worries about multiple situations and activities
most of the time during at least a 6-month period. The
individual finds it hard to control worries. Distress,
inability to focus, tiring easily, irritability, muscle tension,
and sleep disruptions accompany the course of anxiety
and worries (2).
GAD causes a decline in many functional domains
(school, social skills, and family relationships), similar to
other anxiety disorders (3). Adolescents with GAD tend
* Correspondence: drserminyalin@hotmail.com
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to engage in self-harm and self-report suicidal ideation
more frequently, and they exhibit academic difficulties and
intrafamilial conflicts and difficulties in peer relationships
more often than their normal counterparts (4–6). The
diagnosis of GAD is a reported risk factor for alcohol and
nicotine abuse in adolescents (7). It has also been reported
that although GAD has a high prevalence and is a cause of
functional impairment, rates of diagnosis and treatment
appear to be less than what would be expected (8).
GAD is assessed through a clinical interview. The onset
of anxiety symptoms and their evolution during the course
of the disorder, the severity of the anxiety symptoms, the
effect of anxiety symptoms on functioning, and stress
factors related to symptoms are among issues of interest
in the clinical assessment (9). It is particularly important
to ask about thoughts, behaviors, and physical symptoms
related to anxiety (3). Although a clinical interview is the
most common method used for assessment, some self-
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report forms such as the Multidimensional Anxiety Scale
for Children (10), the Screen for Child Anxiety Related
Emotional Disorders (11), the Spence Children’s Anxiety
Scale (12), and the Pediatric Anxiety Rating Scale (13)
are also available for use during evaluation. These scales
are not specific to GAD, but they evaluate the presence of
anxiety disorders based on the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-4)
(3). Although these scales have been shown to be effective
for differentiating children with an anxiety disorder from
those without, it has long been reported that specific scales
based on diagnostic criteria for each anxiety disorder
and appropriate for use in adolescents are warranted for
the diagnostic and follow-up period (14,15). There is no
instrument that specifically measures GAD in Turkey. The
availability of a valid and easily administrable assessment
tool is crucial in precisely identifying the primary problem,
which is also necessary to guide treatment.
The DSM-5 was published in May 2013 (2). One of the
major changes in the DSM-5 is the addition of a dimensional
component to the traditional categorical approach of
previous DSM editions. The categorical system, in which a
diagnosis has only two values (the patient either has or does
not have a disorder), has received considerable criticism.
Psychopathology can vary along multiple dimensions,
such as the number, intensity, and duration of symptoms
experienced and the degree of interference caused by the
symptoms. A dimensional assessment of psychopathology
allows clinicians and researchers to assess the severity of
a disorder, subclinical presentations of a disorder, and
changes in symptoms over time by repeated assessments,
none of which were captured by the categorical diagnostic
system (16). Dimensionality was also strengthened in the
DSM-5 by incorporating severity scales for all disorders
(17). The addition of a severity score to each diagnosis
allows the creation of patient-specific diagnostic profiles
across disorders. Moreover, using a uniform quantitative
score promotes consistency and improves comparability
across studies, which is beneficial for both researchers
and clinicians. Once a categorical anxiety diagnosis has
been made, dimensional ratings allow for a summary of
the severity of an individual’s anxiety symptoms. From
a clinical perspective, this is particularly important with
regard to the choice of treatment type, and it works as well
as observing changes in symptom levels over time does
(16,18).
The DSM-5 Generalized Anxiety Disorder Severity
Scale - Child Form assesses the severity of generalized
anxiety symptoms in children and adolescents aged 11–17
years. It was designed to be used from the first assessment
through follow-up in individuals diagnosed with GAD
who have clinically severe generalized anxiety (17). In a
study with a community sample of children aged 8–13

years in the Netherlands, the scale was shown to be a valid
and reliable tool (18).
The DSM-5 Generalized Anxiety Disorder Severity
Scale - Child Form is the first psychometric tool specific
to the diagnosis of GAD that can be used in children. This
study assessed the validity and reliability of the Turkish
version of the DSM-5 Generalized Anxiety Severity Scale
- Child Form.
2. Materials and methods
2.1. Translation process
To translate the DSM-5 Generalized Anxiety Severity Scale
- Child Form into Turkish, written consent was obtained
from HYB Yayıncılık and Boylam Psikiyatri Enstitüsü, the
Turkish holders of the publication and translation rights for
the DSM-5 Source Book and Handbook for scale studies.
The translation process was performed by two experienced
specialists in the field of child and adolescent psychiatry and
an adult psychiatrist who knew the English language well,
working independently of one another. Then, following
a meeting among members of this team, the translation
was checked and was turned into text. Language usage as
well as cultural, conceptual, and writing appropriateness
were evaluated with the intent of emphasizing conceptual
rather than literal translations and the need to use natural
and acceptable language for the broadest audience. Then
the scale was translated back into English by another adult
psychiatrist who knew the English language well and who
was blinded to any information related to the scale. This
final translation was compared to the original format of
the scale by the whole team with regard to its ability to
match the concepts addressed.
2.2. Participant groups
Healthy volunteers and patients who were being followed
at the Celal Bayar University (CBÜ) Child Psychiatry
Outpatient Unit were included. The clinical sample that
represented the high-risk group regarding psychiatric
symptoms consisted of 32 adolescents aged 11–17 years
who had been followed up at the CBÜ Medical School’s
Child Psychiatry Outpatient Unit with the diagnosis of
GAD according to the DSM-5 criteria. Diagnoses in the
patient group were made through clinical interviews based
on the DSM-5 diagnostic classification system. Inclusion
criteria were age of 11–17 years, meeting the GAD criteria
according to the DSM-5, and sufficient intellectual
functioning to follow the study instructions. The exclusion
criterion was having a physical or a neurological disorder
that would require continuous treatment.
A community sample, which represented the low-risk
group psychiatrically, was collected from schools in the
catchment area. We were granted permission from the
Ministry of Education to select the control group from
secondary and high schools that were similar to the cases

75

YALIN SAPMAZ et al. / Turk J Med Sci
in our unit, and we then administered the scale to students
in randomly selected classrooms. Different criteria have
been applied to conduct multivariate analyses such as
factor analysis for assessing the psychometric properties
of a scale. According to Tavşancıl (19), sample size
needs to be at least 5- to 10-fold the number of question
items in the scale. As this scale contained 10 items, we
planned to include 100 controls; however, as there were
missing data on two forms, we were only able to include
98 controls. Inclusion criteria for the community sample
were age of 11–17 years, not meeting any of the criteria for
a psychiatric or a physical disorder, and having sufficient
intellectual capacity to follow the study instructions.
Reports of families and the school were used as a measure
of general intelligence. Ethical approval was given by the
CBÜ Medical School Clinical Research and Evaluation
Committee.
2.3. Assessment Tools
2.3.1. DSM-5 Generalized Anxiety Disorder Severity
Scale - Child Form
This form has 10 items that determine the severity of
generalized anxiety in children and adolescents. The
individual is asked to rate the severity of generalized
anxiety for each item during the last 7 days. The first five
items assess cognitive and physical symptoms related to
the experience of fear and anxiety; these are assessed based
on intensity and frequency. Each item is rated on a 5-point
scale, ranging from 0 (“none” for intensity, “never” for
frequency) to 4 (“extreme” for intensity, “all of the time” for
frequency). The mean intensity and frequency ratings are
used to create a single score for each item. The next set of
five items assesses the frequency of escape and avoidance
behaviors. The frequency of avoidance behavior is rated
on a 5-point scale ranging from 0 (never) to 4 (all the
time). Total scores vary from 0 to 40, with higher scores
reflecting more severe generalized anxiety. Raw scores of
the 10 items are summed to obtain the total raw score. In
addition, the clinician was asked to calculate and use the
average total score, which condenses the overall score to a
5-point scale, allowing the clinician to think of the child’s
GAD in terms of none (=0), mild (=1), moderate (=2),
severe (=3), or extreme (=4) (17).
2.3.2. Screen for Child Anxiety and Related Disorders
(SCARED)
This scale was developed by Birmaher et al. to screen
anxiety disorders in children (11). SCARED has parent
and child forms; a Turkish validity and reliability study was
conducted by Çakmakçı in 2004 (20). SCARED comprises
41 items, each rated on a 3-point scale with responses of
0 = not true, 1 = sometimes true, and 2 = often true. The
SCARED items are scored on five subscales with labels of
panic/somatic, general anxiety, separation anxiety, social
phobia, and school phobia. The total anxiety score is the
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simple sum of all items. A score of 9 for items 5, 7, 14, 21,
23, 28, 33, 35, and 37 suggests the presence of GAD (11).
2.4. Statistical analysis
The independent-sample t-test was applied to numerical
variables and the chi-square test was used for categorical
variables related to sociodemographic and clinical
features. Correlation analyses were conducted with
Pearson’s correlation analysis. The level of significance
was P ≤ 0.05. The normality of the distributions was
tested with Levene’s test, and all means were found to be
normally distributed. Cronbach’s alpha internal reliability
analysis was performed for the reliability analysis of the
DSM-5 GAD severity scale. The reliability of the scale was
determined by measuring item–total score correlation
coefficients. The scale was readministered to 38 healthy
volunteers at 2 weeks after the initial application, and
test–retest reliability was determined by calculating the
correlation coefficient between the consecutive scores.
Explanatory factor analysis was used to assess the
scale’s construct validity using data derived from the
study groups. First, the Kaiser–Meier–Olkin and Bartlett
tests were used to control for sample congruity for the
explanatory factor analysis. The explanatory factor
analysis was carried out by applying varimax rotation
according to the main compounds method, and factors
with eigenvalues of ≥1 were included in the analysis.
Among the factor constructs, items with factor loadings
of ≥0.4 were included in the analysis. The explanatory
factor constructs were compared to the original dimension
structure of the scale. The correlation between the DSM-5
Generalized Anxiety Disorder Severity Scale - Child Form
and SCARED was measured to assess concurrent validity.
3. Results
This study was conducted with 32 patients who presented
to the CBÜ Child Psychiatry Unit and were diagnosed with
GAD and 98 healthy children who formed the community
sample. The sociodemographic and clinical features of the
study groups are shown in Table 1. Table 2 presents mean
total scores on study measures by sex.
All 32 patients (100%) who formed the clinical sample
were in ongoing treatment. Among these, 68.8% (n = 21)
had a comorbid diagnosis, 31.3% (n = 10) had a specific
phobia, 21.9% (n = 7) had social anxiety disorder, 9.4% (n
= 3) had agoraphobia and panic disorder, 12.5% (n = 4)
had a depressive disorder, and 6.3% (n = 2) had attentiondeficit hyperactivity disorder and separation anxiety
disorder.
3.1. Reliability analyses
Cronbach’s alpha internal consistency coefficient was
0.932. Cronbach’s alpha coefficient for each item is shown
in Table 3. The item–total score correlation coefficients
ranged from 0.566 to 0.810 (Table 3). Data of the 38
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Table 1. Sociodemographic data of the groups.
Generalized anxiety
disorder, N = 32

Community sample,
N = 98

P

15.1 ± 1.99

15.7 ± 1.01

0.152

Female

19 (59.4%)

42 (42.9%)

Male

13 (40.6%)

56 (57.1%)

DSM-5 Generalized Anxiety
Disorder Severity Scale

19.0 ± 9.8

6.3 ± 8.5

0.001

SCARED total score

41.7 ± 15.3

22.5 ± 14.3

0.001

SCARED generalized anxiety
subscale

10.9 ± 5.3

6.6 ± 4.9

0.001

Age
Sex

Scores of the scales applied

0.104

Table 2. Mean total scores of applied scales by sex.
Total sample,
N = 130, mean ± SD

Females,
N = 61, mean ± SD

Males, N = 69,
mean ± SD

DSM-5 Generalized Anxiety
Disorder Scale - Child Form*

9.4 ± 10.4

13.0 ± 11.4

6.3 ± 8.3

Generalized anxiety subscale of SCARED*

7.6 ± 5.4

9.4 ± 5.4

6.0 ± 4.9

SCARED total score*

27.0 ± 16.6

33.3 ± 17.0

21.7 ± 14.3

*P < 0.001.

volunteers who completed the scale a second time were
evaluated to assess test–retest reliability; the correlation
coefficient between the two scale administrations was r =
0.707 (P < 0.001).
3.2. Validity analyses
Before performing explanatory factor analysis, Kaiser–
Meyer–Olkin analysis was applied to assess sample
congruity, resulting in a coefficient of 0.870. The chisquare value by the Bartlett test was 995.763 (P < 0.001).
Thus, explanatory factor analysis was applied to the DSM5 Generalized Anxiety Disorder Severity Scale - Child
form to determine construct validity. In the factor analysis,
one factor had an eigenvalue of >1; that eigenvalue of 6.258
explained 62.6% of the total variance (Table 3).
In the concurrent validity analysis, the correlation
between the DSM-5 Generalized Anxiety Disorder
Severity Scale - Child Form and SCARED was r = 0.731 (P
< 0.001) for the scale total score and r = 0.655 (P < 0.001)
for the generalized anxiety subscale.
4. Discussion
This study explored the validity and reliability of the DSM5 Generalized Anxiety Disorder Severity Scale - Child
Form and showed that the Turkish version is valid and
reliable.

Assessing a scale’s internal consistency indicates
whether the characteristic meant to be measured was
indeed measured. Higher internal consistency values are
important, as they indicate that items used for the measure
actually measure a homogeneous construct. It is commonly
established for psychometric assessments that the closer a
Cronbach’s alpha coefficient value is to 1, the higher the
reliability of the scale is (21). In a reliability analysis for
a children’s group during the original development of the
scale, Cronbach’s alpha coefficient was 0.87 (18). Cronbach’s
alpha coefficient for our scale’s internal consistency was
0.932, indicating that the scale as a whole appropriately
represented the intended construct. The item–total score
correlation coefficients were also high, demonstrating
construct reliability. The test–retest correlation coefficient
between the two scale administrations was r = 0.707. This
value was also significant, supporting the scale’s reliability.
Together, these results indicate that this scale can be used
as a reliable and valid tool.
The concurrent validity analysis evaluated the
correlation between the GAD severity scale and SCARED.
In the first study conducted with children, the correlation
with the generalized anxiety subscale was 0.55 (18). In
our study, the correlation coefficient with the SCARED
generalized anxiety subscale was r = 0.655, indicating
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Table 3. Item–total score correlation coefficients, Cronbach’s alpha coefficients, and factor loads for items of Generalized Anxiety
Disorder Severity Scale - Child Form.
Items

Item–total score
correlation coefficients

Cronbach’s alpha
coefficients

Factor load

Felt moments of sudden terror, fear, or fright

0.763

0.924

0.817

Felt anxious, worried, or nervous

0.810

0.921

0.857

Had thoughts of bad things happening, such as family tragedy,
ill health, loss of a job, or accidents

0.730

0.926

0.787

Felt a racing heart, sweaty, trouble breathing, faint, or shaking

0.714

0.927

0.773

Felt tense muscles, felt on edge or restless, or had trouble
relaxing or trouble sleeping

0.763

0.924

0.819

Avoided, or did not approach or enter, situations about
which they worried

0.752

0.924

0.805

Left situations early or participated only minimally due to worries

0.772

0.923

0.821

Spent lots of time making decisions, putting off making
decisions, or preparing for situations, due to worries

0.774

0.923

0.819

Sought reassurance from others due to worries

0.701

0.928

0.760

Needed help to cope with anxiety (e.g., alcohol or medication,
superstitious objects, or other people)

0.566

0.933

0.631

a medium-level correlation, and that with the total
SCARED score was high, at r = 0.731. A comparison of the
two scales revealed that avoidance behavior and somatic
symptoms were not addressed in the SCARED generalized
anxiety subscale. This might explain the relatively low
correlation coefficient with the SCARED generalized
anxiety subscale, and it may have caused an increase in the
correlation coefficient with the total SCARED score due
to the presence of somatic symptoms in other subscales of
the SCARED. The concurrent validity of the scale supports
the scale as a valid assessment tool.
An explanatory factor analysis used to assess the
DSM-5 GAD severity scale identified a single factor
congruent with the original scale construct (18). The
conceptualization of GAD symptoms in a single construct
indicates high specificity of the scale to the cluster of GAD
symptoms. Thus, the scale would provide clinicians with
clear and unconfounded data, allowing them to monitor
GAD severity.
The presence of both construct validity and concurrent
validity supports the notion that the scale is a valid tool.

Sex differences were in accordance with the literature.
That is, all anxiety disorders were more prevalent in girls
than boys (22,23). In the present study, girls had higher
scores on the SCARED overall scale, the SCARED
generalized anxiety subscale, and the DSM-5 GAD severity
scale.
A limitation of this study was the relatively low number
of subjects in the patient sample, where the patients would
have to consist of individuals within the symptomatic
phase. Another limitation was the lack of a structured
clinical interview for the community sample to determine
diagnoses. All statistical analyses were carried out without
any loss of subjects. A strength of this study might be the
sample size being representative for patients. The scale
score was significantly different in the community and
clinical samples, indicating that the scale can distinguish
a clinical from a normal sample. In this way, the clinical
utility of the scale was proven.
According to these results, we suggest that the DSM-5
Generalized Anxiety Disorder Severity Scale - Child Form
scale can be used effectively in future GAD studies.
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